Isothermal Nucleic Acid Amplification Technology Market by Products (Instrument and Reagent), Technology (NASBA, HAD, LAMP, SDA, SPIA, NEAR, TMA, RCA, RPA, SMAP2, and Others), Applications (Blood Screening, Infectious Disease Diagnostics, Cancer, and Others), End-users (Hospitals, Central & Reference Labs, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global isothermal nucleic acid amplification technology market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising prevalence of infectious diseases.
In the field of molecular biology and recombinant DNA technologies, the isothermal nucleic acid amplification technology (INAAT) is primarily used to identify and analyze nucleic acids. This technique is often used to diagnose infectious, genetic, and inherited disorders quickly, accurately, and precisely using DNA, RNA, cells, proteins, small molecules, and ions. The amplicons created by this technique are used to make a variety of nucleic acid nanomaterials that are employed in biomedicine, bioimaging, and biosensing. They are also used to test for HIV, Tuberculosis, influenza, hepatitis A and B, chlamydia, and gonorrhea (CT/NG), among other infectious disorders.
Wide the rising demand for advanced diagnostic technology, the development of recombinase polymerase amplification (RPA), single primer isothermal amplification (SPIA), and strand displacement amplification (SDA) are key aspects for the market expansion.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing number of cancer and other chronic conditions along with growing demand for effective diagnostic and treatment options are expected to drive the market growth during the forecast period.
- Wide applications of loop-mediated isothermal amplification (LAMP) tests for DNA and RNA amplification as well as the detection of genetically modified organisms (GMOs) are expected to boost the market growth.
- Rising number of aging population worldwide and the increase in the adoption of INAAT over other molecular diagnostic techniques are major factors driving the market growth during the forecast period.
- Stringent rules imposed by organizations such as World Health Organization (WHO) as well as wide reluctance to replace conventional PCR solutions with newer ones among patients in low-income nations are projected to hamper the market growth.
- Lack of awareness and relatively high cost of the advanced diagnostics present as key challenges that can restrict the market expansion during the forecast period.
- Ongoing R&D in the field of microbiology and rapid technological advancements to develop high-ended diagnostic devices are projected to offer lucrative opportunities for the market players.
Scope of the Report
The report on the global isothermal nucleic acid amplification technology market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Isothermal Nucleic Acid Amplification Technology Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Products (Instrument and Reagent), Technology (NASBA, HAD, LAMP, SDA, SPIA, NEAR, TMA, RCA, RPA, SMAP2, and Others), Applications (Blood Screening, Infectious Disease Diagnostics, Cancer, and Others), and End-users (Hospitals, Central & Reference Labs, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Alere, Inc.; bioMerieux SA; Eiken Chemical Co. Ltd.; Hologic, Inc. (Gen-Probe); Lucigen; QIAGEN; Quidel Corporation; Thermo Fisher Scientific; and Becton, Dickinson & Company |
Market Segment Insights
Reagent segment is expected to hold a key share of the market
Based on products, the isothermal nucleic acid amplification technology market is bifurcated into instrument and reagent. The reagent segment is expected to hold a key share of the market during the forecast period owing to considerable usage of the products in hospitals and primary healthcare settings. Consumables and reagents are widely utilized as compared to instruments, which is extensively propelled by growing R&D programs and activities from key players. However, the instruments segment is anticipated to expand at a rapid pace during the forecast period due to the introduction of devices that are improved in terms of precision, speed, and portability.
TMA segment to account for a key market share
On the basis of technology, the market is segmented into SDA, SPIA, NEAR, RCA, RPA, SMAP2, nucleic acid sequence-based amplification (NASBA), helicase-dependent amplification (HDA), loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), and Others. The TMA segment is expected to account for a key share of the market during the forecast period as it is one of the most commercial successful technology widely employed by the players and was the first INAAT introduced in the market. On the other hand, the LAMP and HDA segment is anticipated to expand at a rapid pace during the forecast period.
Infectious disease diagnostics segment is expected to hold a major market share
In terms of applications, the isothermal nucleic acid amplification technology market is segmented into blood screening, infectious disease diagnostics, cancer, and others. The Infectious disease diagnostics segment is expected to hold a major share of the market during the forecast period owing to the introduction of more particular kits and the rising prevalence of disorders such as HIV, hepatitis A and B, and STDs such as chlamydia and gonorrhea. In addition, the growing demand for quick testing to diagnose infectious diseases and prevent the diseases spread particularly in low-income countries is likely to drive growth.
On the other hand, the blood screening segment is anticipated to expand at a rapid pace during the forecast period owing to increased number of blood transfusions across the world. INAAT is extensively used to screen transfused blood for infectious organisms in order to prevent epidemics and limit their spread.
Hospitals segment is expected to register a high CAGR
Based on end-users, the market is divided into hospitals, central & reference labs, and others. The hospitals segment is expected to register a high CAGR during the forecast period due to wide adoption of wireless communication and miniaturized point-of-care devices are being developed, offering single-level access to diagnostic results across the hospital. Automation of a large quantity of samples for infectious disease diagnosis and a requirement for accurate results offered by hospitals are all expected to boost the segment growth.
On the other hand, the central & reference labs segment is anticipated to expand at a rapid pace during the forecast period due to an increasing number of reference laboratories and high adoption of novel & accurate molecular diagnostic techniques.
North America segment is anticipated to dominate the market
On the basis of regions, the isothermal nucleic acid amplification technology market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market with an impressive CAGR during the forecast period. The regional market growth can be attributed to established research infrastructure and rising research initiatives in economies such as the US and Canada. Moreover, increasing demand and investments from foreign players to develop advanced technology for diagnostics products by expanding the scope for the existing research activities in the region play key roles in the regional market expansion.
On the other hand, the market in Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to increase in disposable income, increased investments in healthcare facilities, and unfulfilled clinical demands.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Isothermal Nucleic Acid Amplification Technology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Isothermal Nucleic Acid Amplification Technology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Isothermal Nucleic Acid Amplification Technology Market - Supply Chain
4.5. Global Isothermal Nucleic Acid Amplification Technology Market Forecast
4.5.1. Isothermal Nucleic Acid Amplification Technology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Isothermal Nucleic Acid Amplification Technology Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Isothermal Nucleic Acid Amplification Technology Market Absolute $ Opportunity
5. Global Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
5.3.1. Blood Screening
5.3.2. Infectious Disease Diagnostics
5.3.3. Cancer
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
6.3.1. Hospitals
6.3.2. Central & Reference Labs
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
8. North America Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
8.4.1. Blood Screening
8.4.2. Infectious Disease Diagnostics
8.4.3. Cancer
8.4.4. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
8.7.1. Hospitals
8.7.2. Central & Reference Labs
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
9. Latin America Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
9.4.1. Blood Screening
9.4.2. Infectious Disease Diagnostics
9.4.3. Cancer
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
9.7.1. Hospitals
9.7.2. Central & Reference Labs
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
10. Europe Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
10.4.1. Blood Screening
10.4.2. Infectious Disease Diagnostics
10.4.3. Cancer
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
10.7.1. Hospitals
10.7.2. Central & Reference Labs
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
11. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
11.4.1. Blood Screening
11.4.2. Infectious Disease Diagnostics
11.4.3. Cancer
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
11.7.1. Hospitals
11.7.2. Central & Reference Labs
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
12. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by Applications
12.4.1. Blood Screening
12.4.2. Infectious Disease Diagnostics
12.4.3. Cancer
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Size and Volume Forecast by End Users
12.7.1. Hospitals
12.7.2. Central & Reference Labs
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Isothermal Nucleic Acid Amplification Technology Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Isothermal Nucleic Acid Amplification Technology Market: Market Share Analysis
13.2. Isothermal Nucleic Acid Amplification Technology Distributors and Customers
13.3. Isothermal Nucleic Acid Amplification Technology Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Alere, Inc.
13.4.2. BioMerieux SA
13.4.3. Eiken Chemical Co. Ltd.
13.4.4. Hologic, Inc. (Gen-Probe)
13.4.5. Lucigen
13.4.6. QIAGEN
13.4.7. Quidel Corporation
13.4.8. Thermo Fisher Scientific
13.4.9. Becton, Dickinson & Company
Segments Covered in the Report
The global isothermal nucleic acid amplification technology market has been segmented on the basis of
Products
- Instrument
- Reagent
Technology
- NASBA
- HDA
- LAMP
- SDA
- SPIA
- NEAR
- TMA
- RCA
- RPA
- SMAP2
- Others
Applications
- Blood Screening
- Infectious Disease Diagnostics
- Cancer
- Others
End-users
- Hospitals
- Central & Reference Labs
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Alere, Inc.
- BioMerieux SA
- Eiken Chemical Co. Ltd.
- Hologic, Inc. (Gen-Probe)
- Lucigen
- QIAGEN
- Quidel Corporation
- Thermo Fisher Scientific
- Becton, Dickinson & Company
Key players competing in the isothermal nucleic acid amplification technology market are Alere, Inc.; bioMerieux SA; Eiken Chemical Co. Ltd.; Hologic, Inc. (Gen-Probe); Lucigen; QIAGEN; Quidel Corporation; Thermo Fisher Scientific; and Becton, Dickinson & Company.
Several of these key players are actively engaged in the adoption of various business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and Customized products and applications, which are likely to enhance their market shares.
Our Clients
Related Reports
Some other reports from this category!
